Heparin Treated Articles & Analysis
2 news found
Additionally, an interim safety analysis was performed with a primary safety endpoint of freedom from 30-day major adverse events, which was achieved in all 23 intention-to-treat patients. The primary effectiveness endpoint was measured by time to hemostasis (TTH) after deployment of the device. Thirteen patients were treated without heparin ...
Methods: Patients with a baseline common femoral artery (CFA) diameter of ≥ 6.0 mm were anti-coagulated with IV heparin and treated with ≥14 FR arterial sheaths. Examination of the arterial closure site, distal pulses and vascular ultrasound were performed pre-procedure, immediately post procedure and at 24 hr post procedure. ...